Researcher
Marie Wislez
Persistent identifiers
References for this unit in public registries: they allow cross-checking with other sources and do not change when the name does.
Affiliation
Fields of expertise
Crizotinib
adenocarcinoma
osimertinib
brigatinib
erlotinib
gefitinib
Pemetrexed
durvalumab
10 publications in HAL since 2022.
Data provenance
Sources : scanR, HAL. Data compiled on 27/10/2026. Found an error? It is corrected in the original source (HAL, RNSR, directory); see how.